KRYS – Krystal Biotech, Inc.
Float Short %
13.87
Margin Of Safety %
17
Put/Call OI Ratio
2.56
EPS Next Q Diff
-0.04
EPS Last/This Y
1.8
EPS This/Next Y
3.39
Price
143.98
Target Price
205.82
Analyst Recom
1.17
Performance Q
2.39
Relative Volume
0.99
Beta
0.61
Ticker: KRYS
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-08-15 | KRYS | 150.26 | 1.47 | 0.09 | 14191 |
| 2025-08-18 | KRYS | 146.46 | 1.48 | 0.34 | 6272 |
| 2025-08-19 | KRYS | 143.74 | 1.54 | 1.50 | 6519 |
| 2025-08-20 | KRYS | 145.88 | 1.54 | 196.50 | 6536 |
| 2025-08-21 | KRYS | 145.52 | 1.99 | 2.00 | 7710 |
| 2025-08-22 | KRYS | 150.49 | 1.99 | 5.89 | 7723 |
| 2025-08-25 | KRYS | 146.95 | 2.04 | 24.30 | 7859 |
| 2025-08-26 | KRYS | 146.92 | 2.19 | 0.66 | 8250 |
| 2025-08-27 | KRYS | 147.49 | 2.16 | 3.84 | 8632 |
| 2025-08-28 | KRYS | 150.54 | 2.46 | 13.33 | 9475 |
| 2025-08-29 | KRYS | 147.87 | 2.63 | 5.12 | 9952 |
| 2025-09-02 | KRYS | 149.06 | 2.59 | 86.00 | 9830 |
| 2025-09-03 | KRYS | 150.31 | 2.73 | 0.31 | 10225 |
| 2025-09-04 | KRYS | 149.76 | 2.73 | 1.00 | 10244 |
| 2025-09-05 | KRYS | 150.49 | 2.72 | 0.06 | 10247 |
| 2025-09-08 | KRYS | 145.22 | 2.71 | 0.01 | 10269 |
| 2025-09-09 | KRYS | 140.91 | 2.62 | 0.13 | 10369 |
| 2025-09-10 | KRYS | 137.31 | 2.58 | 0.53 | 10410 |
| 2025-09-11 | KRYS | 144.18 | 2.48 | 0.02 | 10655 |
| 2025-09-12 | KRYS | 143.85 | 2.56 | 0.48 | 10571 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-08-15 | KRYS | 150.37 | -13.0 | -0.3 | 4.92 |
| 2025-08-18 | KRYS | 146.31 | -13.0 | -5.1 | 4.92 |
| 2025-08-19 | KRYS | 143.96 | -13.0 | -3.3 | 4.92 |
| 2025-08-20 | KRYS | 146.08 | -13.0 | 2.3 | 4.92 |
| 2025-08-21 | KRYS | 145.61 | -13.0 | -0.7 | 4.92 |
| 2025-08-22 | KRYS | 150.49 | -13.0 | 5.6 | 4.92 |
| 2025-08-25 | KRYS | 146.66 | -13.0 | -4.9 | 4.92 |
| 2025-08-26 | KRYS | 146.88 | -13.0 | -0.2 | 4.92 |
| 2025-08-27 | KRYS | 147.64 | -13.0 | 0.6 | 4.92 |
| 2025-08-28 | KRYS | 150.76 | -13.0 | 3.4 | 4.92 |
| 2025-08-29 | KRYS | 147.83 | -13.0 | -3.9 | 4.92 |
| 2025-09-02 | KRYS | 149.03 | -13.0 | 1.3 | 4.92 |
| 2025-09-03 | KRYS | 150.18 | -13.0 | 181.3 | 4.92 |
| 2025-09-04 | KRYS | 149.66 | -13.0 | 176.8 | 4.92 |
| 2025-09-05 | KRYS | 150.27 | -13.0 | 180.2 | 4.92 |
| 2025-09-08 | KRYS | 145.20 | -13.0 | 165.6 | 4.92 |
| 2025-09-09 | KRYS | 141.09 | -13.0 | 167.6 | 4.92 |
| 2025-09-10 | KRYS | 137.45 | -13.0 | 168.3 | 4.92 |
| 2025-09-11 | KRYS | 144.36 | -13.0 | 198.8 | 4.92 |
| 2025-09-12 | KRYS | 143.98 | -13.0 | 177.7 | 4.92 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-08-15 | KRYS | -4.69 | 0.01 | 13.67 |
| 2025-08-18 | KRYS | -4.67 | 2.37 | 13.67 |
| 2025-08-19 | KRYS | -4.69 | 2.37 | 13.67 |
| 2025-08-20 | KRYS | -4.69 | 2.37 | 13.67 |
| 2025-08-21 | KRYS | -4.69 | 2.37 | 13.67 |
| 2025-08-22 | KRYS | -4.69 | 2.37 | 13.67 |
| 2025-08-25 | KRYS | -4.69 | 0.45 | 13.67 |
| 2025-08-26 | KRYS | -4.69 | 0.45 | 13.67 |
| 2025-08-27 | KRYS | -4.69 | 0.45 | 14.01 |
| 2025-08-28 | KRYS | -4.69 | 0.45 | 14.01 |
| 2025-08-29 | KRYS | -4.69 | 0.45 | 14.01 |
| 2025-09-02 | KRYS | -4.67 | 0.51 | 14.01 |
| 2025-09-03 | KRYS | -4.67 | 0.51 | 14.01 |
| 2025-09-04 | KRYS | -4.67 | 0.51 | 14.01 |
| 2025-09-05 | KRYS | -4.67 | 0.51 | 14.01 |
| 2025-09-08 | KRYS | -4.67 | 0.47 | 14.01 |
| 2025-09-09 | KRYS | -4.67 | 0.47 | 14.01 |
| 2025-09-10 | KRYS | -4.67 | 0.47 | 14.01 |
| 2025-09-11 | KRYS | -4.67 | 0.47 | 13.87 |
| 2025-09-12 | KRYS | -4.67 | 0.47 | 13.87 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
1.29
Avg. EPS Est. Current Quarter
1.12
Avg. EPS Est. Next Quarter
1.25
Insider Transactions
-4.67
Institutional Transactions
0.47
Beta
0.61
Average Sales Estimate Current Quarter
93
Average Sales Estimate Next Quarter
105
Fair Value
168.92
Quality Score
88
Growth Score
41
Sentiment Score
2
Actual DrawDown %
34.4
Max Drawdown 5-Year %
-53.4
Target Price
205.82
P/E
29.23
Forward P/E
18.32
PEG
0.51
P/S
11.58
P/B
3.99
P/Free Cash Flow
22.43
EPS
4.92
Average EPS Est. Cur. Y
4.92
EPS Next Y. (Est.)
8.31
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
40.85
Relative Volume
0.99
Return on Equity vs Sector %
-10.8
Return on Equity vs Industry %
2.4
EPS 1 7Days Diff
EPS 1 30Days Diff
-1.19
EBIT Estimation
177.7
Krystal Biotech, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 275
Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB105, which is in Phase 1/2 clinical trials for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for treating netherton syndrome; KB407 that is in Phase 1 clinical trials for treating cystic fibrosis; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.
stock quote shares KRYS – Krystal Biotech, Inc. Stock Price stock today
news today KRYS – Krystal Biotech, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch KRYS – Krystal Biotech, Inc. yahoo finance google finance
stock history KRYS – Krystal Biotech, Inc. invest stock market
stock prices KRYS premarket after hours
ticker KRYS fair value insiders trading